GE HealthCare Technologies Inc (GEHC) concluded trading on Thursday at a closing price of $77.43, with 3.38 million shares of worth about $261.99 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -2.20% during that period and on December 19, 2024 the price saw a gain of about 0.44%. Currently the company’s common shares owned by public are about 456.85M shares, out of which, 442.48M shares are available for trading.
Stock saw a price change of -5.15% in past 5 days and over the past one month there was a price change of -6.17%. Year-to-date (YTD), GEHC shares are showing a performance of 0.14% which increased to 2.30% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $71.31 but also hit the highest price of $94.55 during that period. The average intraday trading volume for GE HealthCare Technologies Inc shares is 3.26 million. The stock is currently trading -5.06% below its 20-day simple moving average (SMA20), while that difference is down -8.93% for SMA50 and it goes to -8.08% lower than SMA200.
GE HealthCare Technologies Inc (NASDAQ: GEHC) currently have 456.85M outstanding shares and institutions hold larger chunk of about 80.96% of that.
The stock has a current market capitalization of $35.38B and its 3Y-monthly beta is at 1.32. PE ratio of stock for trailing 12 months is 21.21, while it has posted earnings per share of $3.65 in the same period. Its PEG reads 2.07 and has Quick Ratio of 0.94 while making debt-to-equity ratio of 1.29. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GEHC, volatility over the week remained 2.25% while standing at 1.97% over the month.
Stock’s fiscal year EPS is expected to rise by 9.32% while it is estimated to increase by 8.81% in next year. EPS is likely to grow at an annualized rate of 10.24% for next 5-years, compared to annual growth of -2.54% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by UBS on September 26, 2024 offering a Sell rating for the stock and assigned a target price range of between $84 and $74 to it. Coverage by BTIG Research stated GE HealthCare Technologies Inc (GEHC) stock as a Buy in their note to investors on September 18, 2024, suggesting a price target of $100 for the stock. On September 09, 2024, JP Morgan Initiated their recommendations, while on August 06, 2024, Stifel Initiated their ratings for the stock with a price target of $100. Stock get a Neutral rating from Goldman on May 30, 2024.
